Dawawale Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Noida, Uttar Pradesh, India, established in 2020.
2020 Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Dawawale Pharmaceuticals Limited

Dawawale Pharmaceuticals Limited, a active public limited company, was established on 09 September 2020 in Noida, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290UP2020PLC134254. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.40 M.

Its leadership includes Gopal Prasad Sinha (Director), Nitin Kumar (Director), Nilam Sinha (Director). Past directors included Bhawna Sinha, Arvind Kumar Sinha. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at D-39, Sector-10 Gautam Buddha Nagar, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290UP2020PLC134254

  • Registration Number

    134254

  • Incorporation Date

    09 September 2020

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹4.40 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 4.40 M
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Dawawale Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dawawale Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dawawale Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Gopal Prasad Sinha Director 09 Sep 2020 Current
Nitin Kumar Director 15 Jul 2022 Current
Nilam Sinha Director 09 Sep 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 15 Jul 2022 Past
Pramod Abcsdd Director 22 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dawawale Pharmaceuticals.

Enhance accessibility to Dawawale Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dawawale Pharmaceuticals revenue growth over time
Dawawale Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dawawale Pharmaceuticals?

Unlock access to Dawawale Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dawawale Pharmaceuticals?

Unlock and access historical data on people associated with Dawawale Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dawawale Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dawawale Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dawawale Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dawawale Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Dawawale Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur. was documented.

  • Director Appointment

    Nitin Kumar was appointed as a Director was appointed as a Director on 15 Jul 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Gopal Prasad Sinha was appointed as a Director was appointed as a Director on 09 Sep 2020 & has been associated with this company since 5 years 5 months . was documented.

  • Director Appointment

    The activity Nilam Sinha was appointed as a Director was appointed as a Director on 09 Sep 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Company Incorporation

    Dawawale Pharmaceuticals Limited was registered on 09 Sep 2020 with Roc Kanpur & aged 5 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dawawale Pharmaceuticals Limited?

The CIN of Dawawale Pharmaceuticals Limited is U24290UP2020PLC134254.

Where is Dawawale Pharmaceuticals Limited headquartered?

Dawawale Pharmaceuticals Limited is headquartered at D-39, Sector-10 Gautam Buddha Nagar, Noida, Uttar Pradesh, 201301.

When was Dawawale Pharmaceuticals Limited incorporated?

Dawawale Pharmaceuticals Limited was incorporated on 09 September 2020.

Who are the current directors of Dawawale Pharmaceuticals Limited?

The current directors of Dawawale Pharmaceuticals Limited are

What is the primary industry of Dawawale Pharmaceuticals Limited?

The primary industry of Dawawale Pharmaceuticals Limited is Pharma.

Is Dawawale Pharmaceuticals Limited a listed company?

Dawawale Pharmaceuticals Limited is unlisted.

What is the capital structure of Dawawale Pharmaceuticals Limited?

The authorized capital of Dawawale Pharmaceuticals Limited is ₹5.00 M, and the paid-up capital is ₹4.40 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available